Alopecia androgenética feminina: do diagnóstico ao tratamento

    September 2024 in “ Brazilian Journal of Health Review ”
    Maria Paula Borsari Coelho
    TLDR Female pattern hair loss is common and affects quality of life, but more research is needed for better treatments.
    Alopecia androgenética feminina (APF) is the most common form of hair loss in women, significantly affecting their quality of life. This study reviews 16 scientific articles to explore the diagnosis, epidemiology, pathophysiology, and treatments of APF. Despite extensive research, the hormonal influences on female bodies remain not fully understood, highlighting the need for ongoing research and the development of new therapies.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Well… I Did It. Estrogen Saved My Hairline

      in Transgender  734 upvotes 1 year ago
      OP transitioned and used Spironolactone, Estradiol Valerate, Minoxidil, and dermarolling, resulting in significant hair regrowth. They advise this method may not be suitable for cis men.

      community How is dht not beneficial to you?

      in Finasteride/Dutasteride  111 upvotes 1 month ago
      DHT is important for sexual function and mood, but finasteride and dutasteride can reduce DHT, causing side effects like reduced libido and erectile dysfunction. These treatments are effective for hair loss, but their impact on DHT leads to debate.

      community I wish I were a man so bad. Life is cruel

      in Female  221 upvotes 1 week ago
      A woman with androgenetic alopecia uses Dutasteride and Bicalutamide but feels devastated due to increased sensitivity to DHT. She considers wigs, Minoxidil, and seeks advice on options like spironolactone, hair transplants, and therapy.

      community The meds work: my dad at 23 yo vs me at 35 yo

      in Finasteride/Dutasteride  1791 upvotes 8 months ago
      Finasteride and oral minoxidil effectively maintain a youthful appearance and full head of hair, despite genetic predispositions to balding. The discussion also considers the impact of DHT blockers on masculinity and aging, with lifestyle choices like sunscreen use and a vegetarian diet mentioned.

      community A concern regarding the upcoming androgen degrader drug GT20029

      in Chat  12 upvotes 1 year ago
      GT20029 is a topical treatment that degrades androgen receptors to prevent hair thinning and loss, potentially offering fewer side effects than systemic treatments like finasteride. Concerns include its impact on hair texture and potential systemic effects, with market availability speculated in 3 to 5 years.

    Similar Research

    5 / 1000+ results